<DOC>
	<DOCNO>NCT02063828</DOCNO>
	<brief_summary>The purpose research study compare effect music different level device-guided breathing anxiety shortness breath lung cancer survivor .</brief_summary>
	<brief_title>Reducing Lung Cancer Survivors ' Anxiety Dyspnea ( RELAX )</brief_title>
	<detailed_description>OBJECTIVES 1 . To assess feasibility ( accrual , participation , adherence , retention ) randomize study device-guided breathing music 75 post-treatment ESLC survivor significant anxiety . 2 . To obtain preliminary data variability efficacy two dose device-guided breathe intervention versus music control group reduce anxiety ( primary outcome ) improve self-reported dyspnea respiratory functioning ( secondary outcome ) post-treatment lung cancer survivor . 3 . To select optimal dose device-guided breathing intervention ( 15 minute once/day twice/day ) subsequent randomize study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<criteria>Histologic cytologic diagnosis primary nonsmall cell Stage 0II lung cancer , 2 24 month postcompletion surgery , radiation therapy and/or chemotherapy plan treatment 8week study Score ≥8 anxiety subscale HADS1 Eastern Cooperative Oncology Group performance status 02 Hemoglobin ≥9.5 Smoking status anticipate stable study Willing/able attend brief introductory session use assign device assign period time ( 15 minute twice per day ) , 5 day per week 8 week . Age ≥18 year Patient understand English Active lung infection Radiation pneumonitis currently treat oral steroid Unstable angina Pulmonary embolism past six month Progressive cancer ( must consider evidence disease stable ) Active suicidal ideation plan intent Any change psychotropic medication past month Hearing loss would preclude participate intervention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>